Protara Therapeutics (TARA) Common Equity (2013 - 2026)
Protara Therapeutics' Common Equity was $161.31 million in Q2 2026, up 11.7% from $144.42 million a year earlier but down 11.0% from the prior quarter.
Protara Therapeutics (TARA) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Protara Therapeutics came in at $196.41 million, up 17.5% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
- In earlier years, Common Equity was $167.13 million in FY2024 (+144.6%), $68.32 million in FY2023 (-33.1%), $102.08 million in FY2022 (-37.0%) and $161.91 million in FY2021 (-18.7%).
- Quarterly Common Equity has moved between $58.41 million (Q1 2024) and $196.41 million (Q4 2025) over five years.
- Compared with a year earlier, Common Equity has increased for nine straight quarters, with growth averaging 60.6% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q1 2025 (growth of 171.3%); the worst was Q3 2023 (a decline of 44.7%).
- Per Business Quant data, TARA's Common Equity in the three quarters before Q2 2026 was $181.21 million (Q1 2026), $196.41 million (Q4 2025) and $132.29 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Protara Therapeutics | 149.62 Mn | -411.27 Mn | - | 141.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 141.02 Mn |
| Jun 30, 2026 | 161.31 Mn |
| Mar 31, 2026 | 181.21 Mn |
| Dec 31, 2025 | 196.41 Mn |
| Sep 30, 2025 | 132.29 Mn |
| Jun 30, 2025 | 144.42 Mn |
| Mar 31, 2025 | 158.48 Mn |
| Dec 31, 2024 | 167.13 Mn |
| Sep 30, 2024 | 81.79 Mn |
| Jun 30, 2024 | 92.05 Mn |
| Mar 31, 2024 | 58.41 Mn |
| Dec 31, 2023 | 68.32 Mn |
| Sep 30, 2023 | 76.96 Mn |
| Jun 30, 2023 | 85.23 Mn |
| Mar 31, 2023 | 94.77 Mn |
| Dec 31, 2022 | 102.08 Mn |
| Sep 30, 2022 | 139.18 Mn |
| Jun 30, 2022 | 145.46 Mn |
| Mar 31, 2022 | 152.24 Mn |
| Dec 31, 2021 | 161.91 Mn |
Protara Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TARA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TARA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TARA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();